Guidelines on Bone-modifying Agents in Metastatic Breast Cancer Updated Guidelines on Bone-modifying Agents in Metastatic Breast Cancer Updated

The American Society of Clinical Oncology (ASCO) and Cancer Care Ontario (CCO) have updated their joint recommendations on bone-modifying agents (BMAs) for women with metastatic breast cancer, with an emphasis on dosing intervals and management of bone pain.Reuters Health Information
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Medscape Today News Source Type: news